Chronic restraint stress modulates expression of genes in murine spleen

Journal of Neuroimmunology

Volumn 177, Issue 1-2, 2006, Pages 11-17

  Yin, Deling ^a   Zhang, Ying ^b   Stuart, Charles ^a   Miao, Junying ^c   Zhang, Yi ^a   Li, Chuanfu ^a   Zeng, Xiao ^d   Hanley, Gregory ^a   Moorman, Jonathan ^a   Yao, Zhiqiang ^a   Woodruff, Michael ^a  

^a East Tennessee State University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c SHANDONG UNIVERSITY   (China)

^d SuperArray Bioscience Corporation   (United States)

Author keywords

Apoptosis; Gene expression; Mice; Microarray; Restraint stress

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROTEIN P21; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; IMMOBILIZATION STRESS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; SPLEEN CELL; STATISTICAL SIGNIFICANCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; SPLEEN; STRESS, PSYCHOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 33746296507     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.05.004     Document Type: Article

References (46)

1. Ader R., and Cohen N. Psychoneuroimmunology: conditioning and stress. Annu. Rev. Psychol. 44 (1993) 53-85
2. Beersma M.F., Dirven K., van Dam A.P., Templeton K.E., Claas E.C., and Goossens H. Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J. Clin. Microbiol. 43 (2005) 2277-2285
3. Berthiaume F., Aparicio C.L., Eungdamrong J., and Yarmush M.L. Age- and disease-related decline in immune function: an opportunity for "thymus-boosting" therapies. Tissue Eng. 5 (1999) 499-514
4. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends Cell Biol. 13 (2003) 65-70
5. Debatin K.M., and Krammer P.H. Death receptors in chemotherapy and cancer. Oncogene 23 (2004) 2950-2966
6. Dhabhar F.S., and McEwen B.S. Acute stress enhances while chronic stress suppresses cell-mediated immunity in vivo: a potential role for leukocyte trafficking. Brain Behav. Immun. 11 (1997) 286-306
7. Dhabhar F.S., and McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1059-1064
8. Dominguez-Gerpe L., and Rey-Mendez M. Alterations induced by chronic stress in lymphocyte subsets of blood and primary and secondary immune organs of mice. BMC Immunol. 2 (2001) 7
9. Duggan D.J., Bittner M., Chen Y., Meltzer P., and Trent J.M. Expression profiling using cDNA microarrays. Nat. Genet. 21 (1999) 10-14
10. Frieri M. Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann. Allergy, Asthma, & Immun. 90 (2003) 34-40
11. Galinowski A. Stress and panic. Immunologic aspects. Encephale 19 Spec No 1 (1993) 147-151
12. Garrido C., Galluzzi L., Brunet M., Puig P.E., Didelot C., and Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. (2006) (May 5; [Electronic publication ahead of print])
13. Ghaffari A., Li Y., Karami A., Ghaffari M., Tredget E.E., and Ghahary A. Fibroblast extracellular matrix gene expression in response to keratinocyte-releasable stratifin. J. Cell. Biochem. 98 (2006) 383-393
14. Han S.S., Shaffer A.L., Peng L., Chung S.T., Lim J.H., Maeng S., Kim J.S., McNeil N., Ried T., Staudt L.M., and Janz S. Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1. Mol. Cancer 4 (2005) 40
15. Hingorani R., Bi B., Dao T., Bae Y., Matsuzawa A., and Crispe I.N. CD95/Fas signaling in T lymphocytes induces the cell cycle control protein p21cip-1/WAF-1, which promotes apoptosis. J. Immunol. 164 (2000) 4032-4036
16. Jacks T., and Weinberg R.A. The expanding role of cell cycle regulators. Science 280 (1998) 1035-1036
17. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., and Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 4997-5002
18. Kono K., Takahashi A., Iizuka H., Fujii H., Sekikawa T., and Matsumoto Y. Effect of oesophagectomy on monocyte-induced apoptosis of peripheral blood T lymphocytes. Br. J. Surg. 88 (2001) 1110-1116
19. Kunes P., and Krejsek J. CD4 lymphopenia and postoperative immunosuppression in cardiac surgery. Cas. Lek. Ces. 139 (2000) 361-368
20. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
21. Mahyar-Roemer M., and Roemer K. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20 (2001) 3387-3398
22. Marotti T., Gabrilovac J., Rabatic S., Smejkal-Jagar L., Rocic B., and Haberstock H. Met-enkephalin modulates stress-induced alterations of the immune response in mice. Pharmacol. Biochem. Behav. 54 (1996) 277-284
23. McDermott U., Longley D.B., Galligan L., Allen W., Wilson T., and Johnston P.G. Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer. Cancer Res. 65 (2005) 8951-8960
24. Muller M., Strand S., Hug H., Heinemann E.M., Walczak H., Hofmann W.J., Stremmel W., Krammer P.H., and Galle P.R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99 (1997) 403-413
25. Nagata S., and Golstein P. The Fas death factor. Science 267 (1995) 1449-1456
26. Owen-Schaub L.B., Zhang W., Cusack J.C., Angelo L.S., Santee S.M., Fujiwara T., Roth J.A., Deisseroth A.B., Zhang W.W., and Kruzel E. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15 (1995) 3032-3040
27. Padgett D.A., and Glaser R. How stress influences the immune response. Trends Immunol. 24 (2003) 444-448
28. Polster B.M., Pevsner J., and Hardwick J.M. Viral Bcl-2 homologs and their role in virus replication and associated diseases. Biochim. Biophys. Acta 1644 (2004) 211-227
29. Rabin B.S., Cohen S., Ganguli R., Lysle D.T., and Cunnick J.E. Bidirectional interaction between the central nervous system and the immune system. Crit. Rev. Immunol. 9 (1989) 279-312
30. Renaud S., Hays A.P., Brannagan III T.H., Sander H.W., Edgar M., Weimer L.H., Olarte M.R., Dalakas M.C., Xiang Z., Danon M.J., and Latov N. Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J. Neuroimmunol. 159 (2005) 203-214
31. Satou M., Aizawa S., Hayakari M., Ookawa K., and Tsuchida S. Enhanced sensitivity to cis-diamminedichloroplatinum(II) of a human carcinoma cell line with mutated p53 gene by cyclin-dependent kinase inhibitor p21(WAF1) expression. Cancer Sci. 94 (2003) 286-291
32. Sheridan J.F., Dobbs C., Jung J., Chu X., Konstantinos A., Padgett D., and Glaser R. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann. N. Y. Acad. Sci. 840 (1998) 803-808
33. Sonnenfeld G. Immune responses in space flight. Int. J. Sports Med. 19 Suppl 3 (1998) S195-S202
34. Tamura T., Aoyama N., Saya H., Haga H., Futami S., Miyamoto M., Koh T., Ariyasu T., Tachi M., and Kasuga M. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 11 (1995) 1939-1946
35. Tschopp J., Irmler M., and Thome M. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10 (1998) 552-558
36. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
37. Wan J., Martinvalet D., Ji X., Lois C., Kaech S.M., Von Andrian U.H., Lieberman J., Ahmed R., and Manjunath N. The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes. Immunology 110 (2003) 10-17
38. Wang R., Zhang L., Yin D., Mufson R.A., and Shi Y. Protein kinase C regulates Fas (CD95/APO-1) expression. J. Immunol. 161 (1998) 2201-2207
39. Wang J., Charboneau R., Barke R.A., Loh H.H., and Roy S. Mu-opioid receptor mediates chronic restraint stress-induced lymphocyte apoptosis. J. Immunol. 169 (2002) 3630-3636
40. Webster K.A., Graham R.M., and Bishopric N.H. BNip3 and signal-specific programmed death in the heart. J. Mol. Cell. Cardiol. 38 (2005) 35-45
41. Werner A.B., de Vries E., Tait S.W., Bontjer I., and Borst J. TRAIL receptor and CD95 signal to mitochondria via FADD, caspase-8/10, Bid, and Bax but differentially regulate events downstream from truncated Bid. J. Biol. Chem. 277 (2002) 40760-40767
42. Yang E.V., and Glaser R. Stress-associated immunomodulation and its implications for responses to vaccination. Expert Rev. Vaccines 1 (2002) 453-459
43. Yin D., Mufson R.A., Wang R., and Shi Y. Fas-mediated cell death promoted by opioids. Nature 397 (1999) 218
44. Yin D., Tuthill D., Mufson R.A., and Shi Y. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J. Exp. Med. 191 (2000) 1423-1428
45. Zakowski S.G., McAllister C.G., Deal M., and Baum A. Stress, reactivity, and immune function in healthy men. Health Psychol. 11 (1992) 223-232
46. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkle R., Seligman D.A., and Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001) 199-226